These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

490 related articles for article (PubMed ID: 33459908)

  • 21. Clinicopathological features in membranous nephropathy with cancer: A retrospective single-center study and literature review.
    Zhang D; Zhang C; Bian F; Zhang W; Jiang G; Zou J
    Int J Biol Markers; 2019 Dec; 34(4):406-413. PubMed ID: 31617780
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mannose-Binding Lectin Deposition in Membranous Nephropathy and Differentiation of Primary from Secondary Forms.
    Zdravkova I; Tilkiyan E; Bozhkova D
    Int J Mol Sci; 2024 Jul; 25(14):. PubMed ID: 39062903
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinicopathological characteristics of M-type phospholipase A2 receptor (PLA2R)-related membranous nephropathy in Japanese.
    Hayashi N; Akiyama S; Okuyama H; Matsui Y; Adachi H; Yamaya H; Maruyama S; Imai E; Matsuo S; Yokoyama H
    Clin Exp Nephrol; 2015 Oct; 19(5):797-803. PubMed ID: 25492250
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Retrospective Study of Phospholipase A2 Receptor and IgG Subclasses in Glomerular Deposits in Chinese Patients with Membranous Nephropathy.
    Dong HR; Wang YY; Cheng XH; Wang GQ; Sun LJ; Cheng H; Chen YP
    PLoS One; 2016; 11(5):e0156263. PubMed ID: 27223897
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Primary Membranous Nephropathy.
    Couser WG
    Clin J Am Soc Nephrol; 2017 Jun; 12(6):983-997. PubMed ID: 28550082
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biomarkers to detect membranous nephropathy in Chinese patients.
    Lin L; Wang WM; Pan XX; Xu J; Gao CN; Zhang W; Ren H; Xie JY; Shen PY; Xu YW; Ni LY; Chen N
    Oncotarget; 2016 Oct; 7(42):67868-67879. PubMed ID: 27634909
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neural epidermal growth factor-like 1 protein (NELL-1) associated membranous nephropathy.
    Sethi S; Debiec H; Madden B; Charlesworth MC; Morelle J; Gross L; Ravindran A; Buob D; Jadoul M; Fervenza FC; Ronco P
    Kidney Int; 2020 Jan; 97(1):163-174. PubMed ID: 31901340
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical significance of the determination of antibodies to thrombospondin type 1 containing domain 7A (THSD7A) in membranous nephropathy].
    Kakhsurueva PA; Kamyshova ES; Bobkova IN; Stavrovskaya EV; Rudenko TE; Andreeva EY
    Ter Arkh; 2023 Aug; 95(6):462-467. PubMed ID: 38158964
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PLA2R and THSD7A: Disparate Paths to the Same Disease?
    Beck LH
    J Am Soc Nephrol; 2017 Sep; 28(9):2579-2589. PubMed ID: 28674044
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Autoantibodies against thrombospondin type 1 domain-containing 7A induce membranous nephropathy.
    Tomas NM; Hoxha E; Reinicke AT; Fester L; Helmchen U; Gerth J; Bachmann F; Budde K; Koch-Nolte F; Zahner G; Rune G; Lambeau G; Meyer-Schwesinger C; Stahl RA
    J Clin Invest; 2016 Jul; 126(7):2519-32. PubMed ID: 27214550
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel ELISA for thrombospondin type 1 domain-containing 7A autoantibodies in membranous nephropathy.
    Zaghrini C; Seitz-Polski B; Justino J; Dolla G; Payré C; Jourde-Chiche N; Van de Logt AE; Booth C; Rigby E; Lonnbro-Widgren J; Nystrom J; Mariat C; Cui Z; Wetzels JFM; Ghiggeri G; Beck LH; Ronco P; Debiec H; Lambeau G
    Kidney Int; 2019 Mar; 95(3):666-679. PubMed ID: 30784662
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum Levels of BAFF and APRIL Predict Clinical Response in Anti-PLA2R-Positive Primary Membranous Nephropathy.
    Netti GS; Infante B; Spadaccino F; Godeas G; Corallo MG; Prisciandaro C; Croce L; Rotondi M; Gesualdo L; Stallone G; Grandaliano G; Ranieri E
    J Immunol Res; 2019; 2019():8483650. PubMed ID: 31781684
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An update on clinical significance of use of THSD7A in diagnosing idiopathic membranous nephropathy: a systematic review and meta-analysis of THSD7A in IMN.
    Ren S; Wu C; Zhang Y; Wang AY; Li G; Wang L; Hong D
    Ren Fail; 2018 Nov; 40(1):306-313. PubMed ID: 29623759
    [TBL] [Abstract][Full Text] [Related]  

  • 34. THSD7A staining of membranous glomerulopathy in clinical practice reveals cases with dual autoantibody positivity.
    Larsen CP; Cossey LN; Beck LH
    Mod Pathol; 2016 Apr; 29(4):421-6. PubMed ID: 26847174
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinicopathological Characteristics and Outcomes of PLA
    Luo J; Yuan Y; Tian J; Zhou Z; Su C; Yang F; Wang G
    Am J Kidney Dis; 2022 Sep; 80(3):364-372. PubMed ID: 35288217
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy.
    Tomas NM; Beck LH; Meyer-Schwesinger C; Seitz-Polski B; Ma H; Zahner G; Dolla G; Hoxha E; Helmchen U; Dabert-Gay AS; Debayle D; Merchant M; Klein J; Salant DJ; Stahl RAK; Lambeau G
    N Engl J Med; 2014 Dec; 371(24):2277-2287. PubMed ID: 25394321
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical value of renal phospholipase A2 receptor deposit in the prognosis evaluation and treatment options of idiopathic membranous nephropathy: A retrospective cohort study.
    Xie Z; Dong W; Li Z; Chen Y; Song L; Li R; Wu Y; Fu L; Liang H; Tao Y; Xie J; Wang W; Liu S; Ye Z; Shi W; Liang X
    Nephrology (Carlton); 2020 Mar; 25(3):219-229. PubMed ID: 31900967
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular classification of membranous nephropathy.
    Pozdzik A; Touzani F; Brochériou I; Corazza F
    Curr Opin Nephrol Hypertens; 2019 Jul; 28(4):336-344. PubMed ID: 31045661
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Determination of Anti-Phospholipase A2 and Anti-Thrombospondin Type 1 Domain-Containing Protein 7A in Latin Patients with Membranous Nephropathy.
    Battaini LC; Ranzani OT; Marçal LJ; Antonangelo L; Jorge LB; Bitencourt CD; Woronik V; Malheiros DMA; Yu L
    Diagnostics (Basel); 2022 Dec; 13(1):. PubMed ID: 36611308
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exostosin 1/Exostosin 2-Associated Membranous Nephropathy.
    Sethi S; Madden BJ; Debiec H; Charlesworth MC; Gross L; Ravindran A; Hummel AM; Specks U; Fervenza FC; Ronco P
    J Am Soc Nephrol; 2019 Jun; 30(6):1123-1136. PubMed ID: 31061139
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.